title: Toward reducing risks and costs of egg donation: a preliminary report.
abstract: OBJECTIVE
  To use clomiphene citrate for ovarian stimulation of egg donors as a means of reducing the risk, discomfort, and inconvenience for egg donors and reducing costs for recipients.
  
  
  METHODS
  Prospective nonrandomized clinical study.
  
  
  METHODS
  Private reproductive center.
  
  
  METHODS
  Egg donation recipients and their anonymous donors.
  
  
  METHODS
  Clomiphene citrate was administered to egg donors rather than a GnRH agonist and gonadotropins before oocyte retrieval.
  
  
  METHODS
  Pregnancy.
  
  
  RESULTS
  Eleven oocyte retrievals were performed and conception occurred in four cycles, three of which delivered.
  
  
  CONCLUSIONS
  Clomiphene citrate appears to be a reasonable less expensive method of ovarian stimulation for egg donation in normospermic males and appears more acceptable to potential donors.
authors.affiliation: Faulkner Centre for Reproductive Medicine, Boston, Massachusetts 02130, USA.
authors.forename: M M
authors.initials: MM
authors.lastname: Seibel
mesh_terms: D000328:Adult; D002996:Clomiphene / Q000494:pharmacology*; D003365:Costs and Cost Analysis; D005260:Female; D005306:Fertilization; D006801:Humans; D018587:Oocyte Donation / Q000009:adverse effects* / Q000191:economics*; D010053:Ovary / Q000187:drug effects*; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D002996:Clomiphene